PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $560 | -37.0% | 25,002 | +15.2% | 0.00% | -50.0% |
| Q2 2023 | $889 | -4.4% | 21,702 | +13.3% | 0.00% | 0.0% |
| Q1 2023 | $930 | +14.4% | 19,150 | -9.6% | 0.00% | 0.0% |
| Q4 2022 | $813 | -99.8% | 21,176 | +117.6% | 0.00% | +100.0% |
| Q3 2022 | $488,000 | +261.5% | 9,730 | +188.7% | 0.00% | – |
| Q2 2022 | $135,000 | +0.7% | 3,370 | 0.0% | 0.00% | – |
| Q1 2022 | $134,000 | 0.0% | 3,370 | 0.0% | 0.00% | – |
| Q4 2021 | $134,000 | +6.3% | 3,370 | 0.0% | 0.00% | – |
| Q3 2021 | $126,000 | -11.3% | 3,370 | 0.0% | 0.00% | – |
| Q2 2021 | $142,000 | -27.9% | 3,370 | -19.4% | 0.00% | – |
| Q1 2021 | $197,000 | -22.7% | 4,182 | 0.0% | 0.00% | – |
| Q4 2020 | $255,000 | +30.8% | 4,182 | 0.0% | 0.00% | – |
| Q3 2020 | $195,000 | -7.6% | 4,182 | 0.0% | 0.00% | – |
| Q2 2020 | $211,000 | +34.4% | 4,182 | +19.7% | 0.00% | – |
| Q1 2020 | $157,000 | -5.4% | 3,493 | 0.0% | 0.00% | – |
| Q4 2019 | $166,000 | -32.0% | 3,493 | -35.8% | 0.00% | -100.0% |
| Q2 2019 | $244,000 | +6.6% | 5,442 | -10.9% | 0.00% | 0.0% |
| Q1 2019 | $229,000 | +50.7% | 6,107 | +33.3% | 0.00% | – |
| Q4 2018 | $152,000 | -29.3% | 4,580 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $215,000 | +38.7% | 4,580 | 0.0% | 0.00% | – |
| Q2 2018 | $155,000 | +25.0% | 4,580 | 0.0% | 0.00% | – |
| Q1 2018 | $124,000 | +63.2% | 4,580 | 0.0% | 0.00% | – |
| Q4 2017 | $76,000 | +4.1% | 4,580 | 0.0% | 0.00% | – |
| Q3 2017 | $73,000 | -13.1% | 4,580 | 0.0% | 0.00% | – |
| Q2 2017 | $84,000 | +86.7% | 4,580 | 0.0% | 0.00% | – |
| Q1 2017 | $45,000 | -10.0% | 4,580 | 0.0% | 0.00% | – |
| Q4 2016 | $50,000 | -60.9% | 4,580 | -50.0% | 0.00% | – |
| Q3 2016 | $128,000 | +300.0% | 9,160 | +100.0% | 0.00% | – |
| Q2 2016 | $32,000 | +10.3% | 4,580 | 0.0% | 0.00% | – |
| Q1 2016 | $29,000 | -57.4% | 4,580 | +118.1% | 0.00% | – |
| Q4 2015 | $68,000 | +21.4% | 2,100 | 0.0% | 0.00% | – |
| Q3 2015 | $56,000 | -97.3% | 2,100 | -95.2% | 0.00% | -100.0% |
| Q2 2015 | $2,106,000 | +28.1% | 43,800 | +61.6% | 0.01% | +16.7% |
| Q1 2015 | $1,644,000 | +277.9% | 27,100 | +222.6% | 0.01% | +500.0% |
| Q4 2014 | $435,000 | – | 8,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AXON CAPITAL LP | 216,200 | $9,729,000 | 20.31% |
| GREAT POINT PARTNERS LLC | 1,974,385 | $88,847,000,000 | 9.86% |
| RTW INVESTMENTS, LP | 3,137,361 | $141,181,000 | 7.54% |
| Asymmetry Capital Management, L.P. | 280,542 | $12,624,000 | 6.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 259,000 | $11,642,000 | 4.32% |
| Boxer Capital, LLC | 1,000,000 | $45,000,000 | 3.87% |
| Opaleye Management Inc. | 226,388 | $10,187,000 | 3.10% |
| SECTORAL ASSET MANAGEMENT INC | 450,638 | $20,279,000 | 2.42% |
| SCOPIA CAPITAL MANAGEMENT LP | 983,005 | $44,235,000 | 1.96% |
| Chubb Ltd | 8,180 | $368,000 | 1.82% |